cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2018-4-74-80cardiovascular-710Research ArticleМНЕНИЕ ПО ПРОБЛЕМЕOPINION ON A PROBLEMСовременные эндоваскулярные методы лечения больных с поражением артерий голени: предпосылки и перспективыModern endovascular methods in treatment of patients with the tibial arteries lesion: determinants and perspectiveshttps://orcid.org/0000-0002-6094-4607ЧебанА. В.ChebanA. V.

Врач, сердечно-сосудистый хирург кардиохирургического отделения сосудистой патологии и гибридных технологий.

Novosibirsk

cheban_a@meshalkin.ruhttps://orcid.org/0000-0001-6914-334XКарпенкоА. А.KarpenkoA. A.

Доктор медицинских наук, руководитель центра КХО СПиГТ.

Новосибирск

Novosibirsk

a_karpenko@meshalkin.ruhttps://orcid.org/0000-0002-6911-4650ПоповаИ. В.PopovaI. V.

Врач, сердечно-сосудистый хирург отделения.

Новосибирск

Novosibirsk

irinapopovavladim@mail.ruhttps://orcid.org/0000-0001-6547-6948СааяШ. Б.SaayaSh. B.

Кандидат медицинских наук, врач, сердечно-сосудистый хирург отделения.

Новосибирск

Novosibirsk

shorans@gmail.comhttps://orcid.org/0000-0002-7806-7868ГостевА. А.GostevA. A.

Врач, сердечно-сосудистый хирург отделения.

Новосибирск

Novosibirsk

a_gostev@meshalkin.ruhttps://orcid.org/0000-0003-2803-5937РабцунА. А.RabtsunА. A.

Врач, сердечно-сосудистый хирург отделения.

Новосибирск

Novosibirsk

a_rabtsun@meshalkin.ruhttps://orcid.org/0000-0002-3118-5672НовиковаО. А.NovikovaО. A.

Врач, кардиолог отделения.

Новосибирск

Novosibirsk

Olya_19@bk.ruhttps://orcid.org/0000-0002-0866-0252ЛактионовП. П.LaktionovP. P.

Кандидат биологических наук, заведующий лабораторией биомедицинских технологий центра новых хирургических технологий НМИЦ им. акад. Е.Н. Мешалкина, заведующий лабораторией ИХБФМ СО РАН.

Новосибирск

Novosibirsk

lakt@niboch.nsc.ruФГБУ НМИЦ им акад. Е.Н. Мешалкина МЗ РФMeshalkin National Medical Research Centre«НМИЦ им. академика Е.Н.Мешалкина МЗ РФ Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук.Meshalkin National Medical Research Centre; Institute of Biological Chemistry and Fundamental Medicine of the SD RAS2018200820181747480Copyright © Чебан А.В., Карпенко А.А., Попова И.В., Саая Ш.Б., Гостев А.А., Рабцун А.А., Новикова О.А., Лактионов П.П., 20182018Чебан А.В., Карпенко А.А., Попова И.В., Саая Ш.Б., Гостев А.А., Рабцун А.А., Новикова О.А., Лактионов П.П.Cheban A.V., Karpenko A.A., Popova I.V., Saaya S.B., Gostev A.A., Rabtsun А.A., Novikova О.A., Laktionov P.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/710

Эндоваскулярные вмешательства доказали свою эффективность в лечении поражений артерий голени. Большое количество опубликованных научных работ свидетельствует о сохраняющейся актуальности и перспективе этого направления в настоящее время. В статье представлены анализ исследований за последние 5 лет о разных способах лечения, результаты использования баллонов и стентов с цитостатическими покрытиями. Обозначены пути улучшения результатов интервенционных вмешательств на берцовых артериях при использовании покрытых стентов.

Endovascular interventions have proved efficacy in the treatment of the shin arteries lesion management. Lots of published works witness on the significance and future perspective of the field. The article is focused on the analysis of studies for previous 5 years, on various treatment approaches, balloons and cytostatics coated stents usage. The ways for interventions relsults improvement are sketched on tibial arteries with drug eluting stents.

биорезорбируемые стентылекарственные покрытияангиопластикаатеросклерозbioresorbable stentsdrug coatingangioplasticsatherosclerosisРНФ, 17-75-30009RSF, grant 17-75-30009ReferencesBosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimuseluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vascular Surg. 2012;55.2:390-8. doi:10.1016/j.jvs.2011.07.099.Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimuseluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vascular Surg. 2012;55.2:390-8. doi:10.1016/j.jvs.2011.07.099.Neville RF, Attinger CE, Bulan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vascular Surg. 2009;23(3):367-73. doi:10.1016/j.avsg.2008.08.022.Neville RF, Attinger CE, Bulan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vascular Surg. 2009;23(3):367-73. doi:10.1016/j.avsg.2008.08.022.Fusaro M, Cassese S, Ndrepepa G, et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC: Cardiovascular Interventions 2013;6(12):1284-93. doi:10.1016/j.jcin.2013.08.007.Fusaro M, Cassese S, Ndrepepa G, et al. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials. JACC: Cardiovascular Interventions 2013;6(12):1284-93. doi:10.1016/j.jcin.2013.08.007.Mii S, Tanaka K, Kyuragi R, et al. Raison d’etre of Tibial Artery Bypass for Intermittent Claudication in the Era of Endovascular Therapy. Circulation. 2016;80(6):1460-9. doi:10.1253/circj.CJ-16-0169.Mii S, Tanaka K, Kyuragi R, et al. Raison d’etre of Tibial Artery Bypass for Intermittent Claudication in the Era of Endovascular Therapy. Circulation. 2016;80(6):1460-9. doi:10.1253/circj.CJ-16-0169.Tartaglia E, Lejay A, Georg Y, et al. Results of isolated infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia in high-risk diabetic patients. J Vascular. 2016;24(5):515-22. doi:10.1177/1708538115619265.Tartaglia E, Lejay A, Georg Y, et al. Results of isolated infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia in high-risk diabetic patients. J Vascular. 2016;24(5):515-22. doi:10.1177/1708538115619265.Brodmann M, Froehlich H, Dorr A, et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia. Perkutane transluminale Angioplastie versus primäre Stentimplantation im Bereich der infrapoplitealen Arterien bei Patienten mit kritischer Extremitätenischämie. VasaZeitschrift fur Gefasskrankheiten. 2011;40(6):482. doi:10.1024/0301-1526/a000152.Brodmann M, Froehlich H, Dorr A, et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia. Perkutane transluminale Angioplastie versus primäre Stentimplantation im Bereich der infrapoplitealen Arterien bei Patienten mit kritischer Extremitätenischämie. VasaZeitschrift fur Gefasskrankheiten. 2011;40(6):482. doi:10.1024/0301-1526/a000152.Mustapha JA, Finton SM, Diaz-Sandoval LJ, et al. Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis. Circulation: Cardiovascular Interventions. 2016;9(5):e003468. doi:10.1161/CIRCINTERVENTIONS.115.003468.Mustapha JA, Finton SM, Diaz-Sandoval LJ, et al. Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: systematic review and meta-analysis. Circulation: Cardiovascular Interventions. 2016;9(5):e003468. doi:10.1161/CIRCINTERVENTIONS.115.003468.Faglia E, Clerici G, Clerissi J, et al. When is a technically successful peripheral angioplasty effective in preventing above‐the‐ankle amputation in diabetic patients with critical limb ischaemia? Diabetic Medicine. 2017;24(8):823-9. doi:10.1111/j.1464-5491.2007.02167.x.Faglia E, Clerici G, Clerissi J, et al. When is a technically successful peripheral angioplasty effective in preventing above‐the‐ankle amputation in diabetic patients with critical limb ischaemia? Diabetic Medicine. 2017;24(8):823-9. doi:10.1111/j.1464-5491.2007.02167.x.Fanelli Fabrizio, Alessandro Cannavale. Drug coated balloons below-the-knee: just too early? J Cardiovasc Surg. 2016;57(1):18-22. PMID 26771722.Fanelli Fabrizio, Alessandro Cannavale. Drug coated balloons below-the-knee: just too early? J Cardiovasc Surg. 2016;57(1):18-22. PMID 26771722.Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. JACC. 2012;60(22):2290-5. doi:10.1016/j. jacc.2012.08.989.Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. JACC. 2012;60(22):2290-5. doi:10.1016/j. jacc.2012.08.989.Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vascul Surg. 2012;55(2):363-70. doi:10.1016/j.jvs.2011.08.014.Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vascul Surg. 2012;55(2):363-70. doi:10.1016/j.jvs.2011.08.014.Kelsch B, Scheller B, Biedermann M, et al. Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Investigative radiology. 2011;46(4):255-63. doi:10.1097/RLI.0b013e31820577df.Kelsch B, Scheller B, Biedermann M, et al. Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Investigative radiology. 2011;46(4):255-63. doi:10.1097/RLI.0b013e31820577df.Krokidis M, Spiliopoulos S, Katsanos K, et al. Peripheral applications of drug-coated balloons: past, present and future. Cardiovasc Intervent Radiol. 2013;36(2):281-91. doi:10.1007/s00270-012-0467-0.Krokidis M, Spiliopoulos S, Katsanos K, et al. Peripheral applications of drug-coated balloons: past, present and future. Cardiovasc Intervent Radiol. 2013;36(2):281-91. doi:10.1007/s00270-012-0467-0.Pavé M, Benadiba L, Berger L, et al. Below-the-knee angioplasty for critical limb ischemia: results of a series of 157 procedures and impact of the angiosome concept. Ann Vascular Surg. 2016;36:199-207. doi:10.1016/j.avsg.2016.03.032.Pavé M, Benadiba L, Berger L, et al. Below-the-knee angioplasty for critical limb ischemia: results of a series of 157 procedures and impact of the angiosome concept. Ann Vascular Surg. 2016;36:199-207. doi:10.1016/j.avsg.2016.03.032.Brosi P, Baumgartner I, Silvestro A, et al. Outcomes and influence of the pedal arch in below-the-knee angioplasty in patients with end-stage renal disease and critical limb ischemia. Ann Vascular Surg. 2016;35:121-9. doi:10.1016/j.avsg.2016.01.039.Brosi P, Baumgartner I, Silvestro A, et al. Outcomes and influence of the pedal arch in below-the-knee angioplasty in patients with end-stage renal disease and critical limb ischemia. Ann Vascular Surg. 2016;35:121-9. doi:10.1016/j.avsg.2016.01.039.Randon C, Jacobs B, De Ryck F, et al. Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial. Cardiovascular and interventional radiology. 2010;33(2):260-9. doi:10.1007/s00270-009-9765-6.Randon C, Jacobs B, De Ryck F, et al. Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial. Cardiovascular and interventional radiology. 2010;33(2):260-9. doi:10.1007/s00270-009-9765-6.Jens S, Conijn AP, Koelemay MJ, et al. Randomized Trials for Endovascular Treatment of Infrainguinal Arterial Disease: Systematic Review and Meta-analysis (Part 2: Below the Knee). Eur J Vasc Endovasc Surg. 2014;47(5):536-44. doi:10.1016/j.ejvs.2014.02.012.Jens S, Conijn AP, Koelemay MJ, et al. Randomized Trials for Endovascular Treatment of Infrainguinal Arterial Disease: Systematic Review and Meta-analysis (Part 2: Below the Knee). Eur J Vasc Endovasc Surg. 2014;47(5):536-44. doi:10.1016/j.ejvs.2014.02.012.Bedoya J, Meyer CA, Timmins LH, et al. Effects of stent design parameters on normal artery wall mechanics. J Biomechanic Engineer. 2006;128(5):757-65. doi:10.1115/1.2246236.Bedoya J, Meyer CA, Timmins LH, et al. Effects of stent design parameters on normal artery wall mechanics. J Biomechanic Engineer. 2006;128(5):757-65. doi:10.1115/1.2246236.Müller-Leisse C, Janssen R, Hajeck KL, et al. Long iliac artery occlusions: feasibility, short-and mid-term outcome. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2001;173(12):1079-85. doi:10.1055/s-2001-18890.Müller-Leisse C, Janssen R, Hajeck KL, et al. Long iliac artery occlusions: feasibility, short-and mid-term outcome. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2001;173(12):1079-85. doi:10.1055/s-2001-18890.Hernigou J, Gordienco A, Dakhil B, et al. Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon. J Malad Vasculair. 2015;40(4):259-64. doi:10.1016/j.jmv.2015.05.004.Hernigou J, Gordienco A, Dakhil B, et al. Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon. J Malad Vasculair. 2015;40(4):259-64. doi:10.1016/j.jmv.2015.05.004.Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vascular and Endovascular Surg. 2007;33(4):453-60. doi:10.1016/j.ejvs.2006.11.022.Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vascular and Endovascular Surg. 2007;33(4):453-60. doi:10.1016/j.ejvs.2006.11.022.Patel SD, Biasi L, Paraskevopoulos I, et al. Comparison of angioplasty and bypass surgery for critical limb ischaemia in patients with infrapopliteal peripheral artery disease. BJS. 2016;103(13):1815-22. doi:10.1002/bjs.10292.Patel SD, Biasi L, Paraskevopoulos I, et al. Comparison of angioplasty and bypass surgery for critical limb ischaemia in patients with infrapopliteal peripheral artery disease. BJS. 2016;103(13):1815-22. doi:10.1002/bjs.10292.Siablis D, Kitrou PM, Spiliopoulos S, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC: Cardiovascular Interventions. 2014;7(9):1048-56. doi:10.1016/j.jcin.2014.04.015.Siablis D, Kitrou PM, Spiliopoulos S, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC: Cardiovascular Interventions. 2014;7(9):1048-56. doi:10.1016/j.jcin.2014.04.015.Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation: Cardiovascular Interventions. 2012;5(6):831-40. doi:10.1161/CIRCINTERVENTIONS.112.971630.Werk M, Albrecht T, Meyer DR, et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circulation: Cardiovascular Interventions. 2012;5(6):831-40. doi:10.1161/CIRCINTERVENTIONS.112.971630.Zeller T, Beschorner U, Pilger E, et al. Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK’Sfirst in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC: Cardiovascular Interventions. 2015;8(12):1614-22. doi:10.1016/j.jcin.2015.07.011.Zeller T, Beschorner U, Pilger E, et al. Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK’Sfirst in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC: Cardiovascular Interventions. 2015;8(12):1614-22. doi:10.1016/j.jcin.2015.07.011.Steiner S, Schmidt A, Bausback Y, et al. Single-center experience with lutonix drugcoated balloons in infrapopliteal arteries. J Endovasc Ther. 2016;23(3):417-23. doi:10.1177/1526602816645080.Steiner S, Schmidt A, Bausback Y, et al. Single-center experience with lutonix drugcoated balloons in infrapopliteal arteries. J Endovasc Ther. 2016;23(3):417-23. doi:10.1177/1526602816645080.Zhang J, Xu X, Kong J, et al. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization. Vascular Endovascular Surgery. 2017;51(2):72-83. doi:10.1177/1538574416689426.Zhang J, Xu X, Kong J, et al. Systematic Review and Meta-Analysis of Drug-Eluting Balloon and Stent for Infrapopliteal Artery Revascularization. Vascular Endovascular Surgery. 2017;51(2):72-83. doi:10.1177/1538574416689426.Oz II, Serifoglu I, Bilici M, et al. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients. Vascular Endovascular Surg. 2016;50(8):534-40. doi:10.1177/1538574416676019.Oz II, Serifoglu I, Bilici M, et al. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients. Vascular Endovascular Surg. 2016;50(8):534-40. doi:10.1177/1538574416676019.Xiao Y, Chen Z, Yang Y, et al. Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease. Diagnostic and Interventional Radiology. 2016;22(5):436. doi:10.5152/dir.2016.15430.Xiao Y, Chen Z, Yang Y, et al. Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease. Diagnostic and Interventional Radiology. 2016;22(5):436. doi:10.5152/dir.2016.15430.Varcoe RL, Schouten O, Thomas SD, et al. Experience with the absorb everolimuseluting bioresorbable vascular scaffold in arteries below the knee: 12-month clinical and imaging outcomes. JACC: Cardiovascular Interventions. 2016;9(16):1721-8. doi:10.1016/j.jcin.2016.06.005.Varcoe RL, Schouten O, Thomas SD, et al. Experience with the absorb everolimuseluting bioresorbable vascular scaffold in arteries below the knee: 12-month clinical and imaging outcomes. JACC: Cardiovascular Interventions. 2016;9(16):1721-8. doi:10.1016/j.jcin.2016.06.005.Galyfos G, Geropapas G, Stefanidis I, et al. Bioabsorbable stenting in peripheral artery disease. Cardiovascular Revascularization Med. 2015;16(8):480-3. doi:10.1016/j.carrev.2015.08.005.Galyfos G, Geropapas G, Stefanidis I, et al. Bioabsorbable stenting in peripheral artery disease. Cardiovascular Revascularization Med. 2015;16(8):480-3. doi:10.1016/j.carrev.2015.08.005.Karpenko A, Starodubtsev V, Ignatenko P, et al. Endovascular treatment of the subclavian artery steno-occlusive disease. J Stroke and Cerebrovascular Diseases. 2017;26(1): 87-93. doi:10.1016/j.jstrokecerebrovasdis.2016.08.034.Karpenko A, Starodubtsev V, Ignatenko P, et al. Endovascular treatment of the subclavian artery steno-occlusive disease. J Stroke and Cerebrovascular Diseases. 2017;26(1): 87-93. doi:10.1016/j.jstrokecerebrovasdis.2016.08.034.Biasi L, Patel SD, Lea T, et al. Complex infrapopliteal revascularization in elderly patients with critical limb ischemia: impact of multidisciplinary integrated care on mid-term outcome. The J Сardiovasc Surg. 2017;58(5):665-73. doi:10.23736/S00219509.16.09159-X.Biasi L, Patel SD, Lea T, et al. Complex infrapopliteal revascularization in elderly patients with critical limb ischemia: impact of multidisciplinary integrated care on mid-term outcome. The J Сardiovasc Surg. 2017;58(5):665-73. doi:10.23736/S00219509.16.09159-X.Popplewell MA, Davies HOB, Narayanswami J, et al. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial. Eur J Vasc and Endovasc Surg. 2017;54(2):195-201. doi:10.1016/j.ejvs.2017.04.020.Popplewell MA, Davies HOB, Narayanswami J, et al. A Comparison of Outcomes in Patients with Infrapopliteal Disease Randomised to Vein Bypass or Plain Balloon Angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial. Eur J Vasc and Endovasc Surg. 2017;54(2):195-201. doi:10.1016/j.ejvs.2017.04.020.Conte MS. Diabetic revascularization: endovascular versus open bypass — do we have the answer? Seminars in Vascular Surg. 2012;25(2). WB Saunders. doi:10.1053/j.semvascsurg.2012.04.004.Conte MS. Diabetic revascularization: endovascular versus open bypass — do we have the answer? Seminars in Vascular Surg. 2012;25(2). WB Saunders. doi:10.1053/j.semvascsurg.2012.04.004.Varela C, Acin F, De JH, et al. Influence of surgical or endovascular distal revascularization of the lower limbs on ischemic ulcer healing. J Сardiovasc Surg. 2011;52(3):381-9. PMID 21577193.Varela C, Acin F, De JH, et al. Influence of surgical or endovascular distal revascularization of the lower limbs on ischemic ulcer healing. J Сardiovasc Surg. 2011;52(3):381-9. PMID 21577193.Utsunomiya M, Nakamura M, Nakanishi M, et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vascular Surg. 2012;55(1):113-21. doi:10.1016/j.jvs.2011.08.001.Utsunomiya M, Nakamura M, Nakanishi M, et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vascular Surg. 2012;55(1):113-21. doi:10.1016/j.jvs.2011.08.001.

The authors declare that there are no conflicts of interest present.